Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : ARTL save search
Artelo Biosciences Announces Publication of Peer-Reviewed Article Highlighting FABP7 as a Promising Novel Target in Cancer Therapy
Published: 2024-04-23 (Crawled : 12:30) - globenewswire.com
ARTL | News | $1.31 0.74% 1.87% 16K
|
Health Technology
|
| O: 0.77%
H: 2.29%
C: 0.0%
cancer publication therapy
Artelo Biosciences CEO to Appear on Benzinga All Access on April 23rd at Approximately 10:50 AM Eastern Time
Published: 2024-04-22 (Crawled : 13:00) - globenewswire.com
ARTL | News | $1.31 0.74% 1.87% 16K
|
Health Technology
|
| O: 5.34%
H: 0.0%
C: -5.8%
ceo
Artelo Biosciences Reports Fiscal 2023 Year-End Financial Results and Provides Business UpdateMajor achievements in 2023 lay the foundation for key upcoming milestones
Published: 2024-03-25 (Crawled : 16:00) - biospace.com/
AZNCF | News | $140.3 1.13% -4.19% 1.5K
|
Health Technology
|
| O: 0.75%
H: 0.04%
C: -0.1%
AZN | News | $70.85 1.03% 1.02% 4.9M
|
Health Technology
|
| O: -0.08%
H: 0.33%
C: -0.53%
ARTL | News | $1.31 0.74% 1.87% 16K
|
Health Technology
|
| O: -4.61%
H: 4.83%
C: 3.84%
business lay key financial results foundation
Artelo Biosciences Reports Fiscal 2023 Year-End Financial Results and Provides Business Update
Published: 2024-03-25 (Crawled : 12:00) - globenewswire.com
AZNCF | News | $140.3 1.13% -4.19% 1.5K
|
Health Technology
|
| O: 0.75%
H: 0.04%
C: -0.1%
AZN | News | $70.85 1.03% 1.02% 4.9M
|
Health Technology
|
| O: -0.08%
H: 0.33%
C: -0.53%
ARTL | News | $1.31 0.74% 1.87% 16K
|
Health Technology
|
| O: -4.61%
H: 4.83%
C: 3.84%
business update financial results
Artelo Biosciences Selected as a Finalist in Johnson & Johnson’s Innovation Challenge
Published: 2024-03-12 (Crawled : 13:00) - globenewswire.com
JNJ | News | $149.56 0.3% -0.17% 6.9M
|
Health Technology
|
| O: 1.12%
H: 0.0%
C: 0.0%
ARTL | News | $1.31 0.74% 1.87% 16K
|
Health Technology
|
| O: 2.01%
H: 6.41%
C: 0.36%
innovation
Artelo Biosciences Announces Publication of New Peer-Reviewed Pre-Clinical Research Demonstrating ART26.12’s Effectiveness in Treating and Preventing Oxaliplatin-Induced Peripheral Neuropathy
Published: 2024-01-23 (Crawled : 13:30) - globenewswire.com
ARTL | News | $1.31 0.74% 1.87% 16K
|
Health Technology
|
| O: 0.0%
H: 3.6%
C: -0.72%
art26 pre-clinical publication research
Artelo Biosciences Announces Selection of Worldwide Clinical Trials as Clinical Research Organization to Support First-in-Human Study of ART26.12
Published: 2024-01-08 (Crawled : 14:00) - globenewswire.com
ARTL | News | $1.31 0.74% 1.87% 16K
|
Health Technology
|
| O: 3.09%
H: 0.0%
C: -3.65%
art26 worldwide trials research study
Artelo Biosciences Presents New Preclinical Data on ART12.11 at the 4th Annual Med-Cannabis 2023 Conference in Germany
Published: 2023-12-05 (Crawled : 13:30) - globenewswire.com
ARTL | News | $1.31 0.74% 1.87% 16K
|
Health Technology
|
| O: -0.7%
H: 8.51%
C: 4.96%
art12 conference germany preclinical
Artelo Biosciences to Present Important New Preclinical Data on ART12.11 at the 4th Annual Med-Cannabis 2023 Conference in Germany
Published: 2023-11-30 (Crawled : 15:00) - biospace.com/
ARTL | News | $1.31 0.74% 1.87% 16K
|
Health Technology
|
| O: 6.36%
H: 0.0%
C: -5.48%
art12 conference germany preclinical
Artelo Biosciences Reports Third Quarter 2023 Financial Results and Provides Business Update
Published: 2023-11-13 (Crawled : 13:30) - globenewswire.com
ARTL | News | $1.31 0.74% 1.87% 16K
|
Health Technology
|
| O: -2.36%
H: 2.82%
C: 2.42%
business update financial results
Artelo Biosciences Announces Publication of New Peer-Reviewed Research Demonstrating Protective Properties of ART27.13 Against Muscle Degeneration Caused by Certain Cancers
Published: 2023-11-09 (Crawled : 14:00) - globenewswire.com
AZNCF | News | $140.3 1.13% -4.19% 1.5K
|
Health Technology
|
| O: 2.33%
H: 0.83%
C: -0.88%
AZN | News | $70.85 1.03% 1.02% 4.9M
|
Health Technology
|
| O: 2.72%
H: 0.49%
C: -1.79%
ARTL | News | $1.31 0.74% 1.87% 16K
|
Health Technology
|
| O: 3.47%
H: 0.0%
C: -11.41%
art27 art27.13 publication research
Artelo Biosciences to Present Preclinical Data Showcasing Research on ART26.12 and ART12.11 in Anxiety and Depression at Neuroscience 2023
Published: 2023-11-02 (Crawled : 12:00) - globenewswire.com
ARTL | News | $1.31 0.74% 1.87% 16K
|
Health Technology
|
| O: 1.64%
H: 1.6%
C: 0.8%
art26 depression research preclinical
Principal Investigator of Artelo’s CAReS Trial to Participate in Medical Expert Webinar Hosted by H.C. Wainwright to Discuss Current Development Strategies for Cancer-Related Anorexia and Cachexia
Published: 2023-10-04 (Crawled : 13:00) - globenewswire.com
AZNCF | News | $140.3 1.13% -4.19% 1.5K
|
Health Technology
|
| O: 0.92%
H: 0.0%
C: 0.0%
AZN | News | $70.85 1.03% 1.02% 4.9M
|
Health Technology
|
| O: 0.42%
H: 0.3%
C: 0.12%
ARTL | News | $1.31 0.74% 1.87% 16K
|
Health Technology
|
| O: 5.84%
H: 0.0%
C: -3.45%
cares medical trial
Artelo Biosciences to Present at the 13th Congress of the European Pain Federation on September 20th
Published: 2023-09-13 (Crawled : 12:30) - globenewswire.com
ARTL | News | $1.31 0.74% 1.87% 16K
|
Health Technology
|
| O: -0.63%
H: 1.9%
C: -1.91%
congress
Artelo Biosciences Completes Positive Pre-IND Meeting with FDA for ART26.12Announces Plans to File IND Application in Neuropathic Pain
Published: 2023-09-07 (Crawled : 17:00) - biospace.com/
ARTL | News | $1.31 0.74% 1.87% 16K
|
Health Technology
|
| O: 3.83%
H: 22.13%
C: -25.45%
art26 fda positive meeting application
Artelo Biosciences Completes Positive Pre-IND Meeting with FDA for ART26.12
Published: 2023-09-07 (Crawled : 12:00) - globenewswire.com
ARTL | News | $1.31 0.74% 1.87% 16K
|
Health Technology
|
| O: 3.83%
H: 22.13%
C: -25.45%
art26 fda positive meeting
Artelo Biosciences to Present at the 6th Cannabinoid-Derived Drug Development Summit on September 12th
Published: 2023-09-06 (Crawled : 13:00) - globenewswire.com
ARTL | News | $1.31 0.74% 1.87% 16K
|
Health Technology
|
| O: -0.01%
H: 45.95%
C: 27.03%
drug
Artelo Biosciences to Present at the H.C. Wainwright 25th Annual Global Investment Conference on September 13th
Published: 2023-09-05 (Crawled : 13:00) - globenewswire.com
ARTL | News | $1.31 0.74% 1.87% 16K
|
Health Technology
|
| O: 0.27%
H: 0.25%
C: -1.33%
conference global
Artelo Biosciences Reports Second Quarter 2023 Financial Results and Provides Business Update
Published: 2023-08-10 (Crawled : 12:00) - globenewswire.com
ARTL | News | $1.31 0.74% 1.87% 16K
|
Health Technology
|
| O: -3.05%
H: 4.71%
C: 3.14%
business update financial results
Artelo Biosciences to Present New Mechanism of Action Data on ART26.12 at the Gordon Research Conference on July 20, 2023
Published: 2023-07-19 (Crawled : 13:00) - globenewswire.com
ARTL | News | $1.31 0.74% 1.87% 16K
|
Health Technology
|
| O: 4.74%
H: 0.0%
C: -3.52%
art26 conference research
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 26M
|
AGBA | $2.97 137.6% 57.48% 66M
|
Finance
EDBL | News | $6.59 75.27% 41.8% 2M
|
ZAPP | $4.44 50.2% 33.12% 370K
|
n/a
MTC | $2.24 43.59% 30.67% 6M
|
Technology Services
OPRT | News | $3.15 40.0% 29.13% 12M
|
Finance
SHIM | $3.045 35.33% 26.23% 870K
|
HKIT | $1.33 30.39% 24.16% 390K
|
Technology Services
ABVC | $1.35 29.81% 23.53% 7.1M
|
Wholesale Trade
OST | $0.5 25.0% 21.88% 280K
|
Your saved searches
Save your searches and get alerts when important news are released.